MedTrace Logo

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

NCT02331589 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2015-02-10

Study results available
· View outcomes & findings →

Summary

Background: Korea red ginseng (KRG) has anti-carcinogenic activity, anti-oxidant activity, and cancer related anti-fatigue.

Methods: Seventy five patients with non-alcoholic hepatitis were prospectively randomized to receive 3 weeks of KRG or placebo. Liver function test, pro-inflammatory cytokines, adiponectin, fatigue severity scale, and antioxidant activity were check and compared.

Conditions

Interventions

DRUG

KRG (Korea Red ginseng)

3 weeks of KRG capsule (3,000 mg/day)

DRUG

Placebo (for KRG)

Placebos with same shape and size were manufactured and at Korea Ginseng Corporation

Sponsors & Collaborators

  • Chuncheon Sacred Heart Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-04-30
Completion
2012-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331589 on ClinicalTrials.gov